FLUTICASONE FUROATE\SALMETEROL: 750 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
750
Total FAERS Reports
57 (7.6%)
Deaths Reported
339
Hospitalizations
750
As Primary/Secondary Suspect
53
Life-Threatening
39
Disabilities
Active Ingredient: FLUTICASONE FUROATE\SALMETEROL XINAFOATE ·
First Report: 1994 · Latest Report: 20220602
What Are the Most Common FLUTICASONE FUROATE\SALMETEROL Side Effects?
#1 Most Reported
Asthma
132 reports (17.6%)
#2 Most Reported
Dyspnoea
114 reports (15.2%)
#3 Most Reported
Drug ineffective
101 reports (13.5%)
All FLUTICASONE FUROATE\SALMETEROL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 132 | 17.6% | 14 | 91 |
| Dyspnoea | 114 | 15.2% | 4 | 71 |
| Drug ineffective | 101 | 13.5% | 4 | 51 |
| Pneumonia | 90 | 12.0% | 14 | 49 |
| Cough | 82 | 10.9% | 0 | 27 |
| Product quality issue | 59 | 7.9% | 2 | 29 |
| Off label use | 57 | 7.6% | 4 | 35 |
| Wheezing | 51 | 6.8% | 1 | 31 |
| Overdose | 49 | 6.5% | 4 | 33 |
| Lower respiratory tract infection | 47 | 6.3% | 8 | 19 |
| Condition aggravated | 41 | 5.5% | 3 | 32 |
| Asthmatic crisis | 38 | 5.1% | 0 | 17 |
| Malaise | 37 | 4.9% | 8 | 23 |
| Death | 33 | 4.4% | 33 | 9 |
| Therapeutic product effect incomplete | 33 | 4.4% | 1 | 24 |
| Productive cough | 31 | 4.1% | 3 | 21 |
| Chronic obstructive pulmonary disease | 28 | 3.7% | 3 | 21 |
| Fatigue | 27 | 3.6% | 1 | 12 |
| Loss of personal independence in daily activities | 26 | 3.5% | 1 | 20 |
| Nasopharyngitis | 26 | 3.5% | 0 | 18 |
Who Reports FLUTICASONE FUROATE\SALMETEROL Side Effects? Age & Gender Data
Gender: 49.9% female, 50.1% male. Average age: 55.8 years. Most reports from: CN. View detailed demographics →
Is FLUTICASONE FUROATE\SALMETEROL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 0 |
| 2005 | 3 | 1 | 0 |
| 2006 | 5 | 0 | 3 |
| 2007 | 5 | 0 | 4 |
| 2008 | 22 | 0 | 1 |
| 2009 | 4 | 0 | 2 |
| 2010 | 6 | 0 | 3 |
| 2011 | 10 | 1 | 6 |
| 2012 | 15 | 0 | 7 |
| 2013 | 26 | 0 | 17 |
| 2014 | 111 | 11 | 58 |
| 2015 | 137 | 6 | 67 |
| 2016 | 8 | 0 | 6 |
| 2017 | 3 | 0 | 2 |
| 2018 | 4 | 0 | 2 |
| 2019 | 2 | 0 | 0 |
| 2020 | 5 | 0 | 4 |
| 2021 | 6 | 0 | 0 |
| 2022 | 4 | 0 | 0 |
What Is FLUTICASONE FUROATE\SALMETEROL Used For?
| Indication | Reports |
|---|---|
| Asthma | 286 |
| Product used for unknown indication | 247 |
| Chronic obstructive pulmonary disease | 94 |
| Emphysema | 18 |
| Bronchitis | 10 |
| Respiratory disorder | 8 |
| Dyspnoea | 6 |
FLUTICASONE FUROATE\SALMETEROL vs Alternatives: Which Is Safer?
FLUTICASONE FUROATE\SALMETEROL vs FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE
FLUTICASONE FUROATE\SALMETEROL vs FLUTICASONE FUROATE\VILANTEROL TRIFENATATE
FLUTICASONE FUROATE\SALMETEROL vs FLUTICASONE\FLUTICASONE
FLUTICASONE FUROATE\SALMETEROL vs FLUTICASONE\FORMOTEROL
FLUTICASONE FUROATE\SALMETEROL vs FLUTICASONE\SALMETEROL
FLUTICASONE FUROATE\SALMETEROL vs FLUVASTATIN
FLUTICASONE FUROATE\SALMETEROL vs FLUVOXAMINE
FLUTICASONE FUROATE\SALMETEROL vs FOLATE
FLUTICASONE FUROATE\SALMETEROL vs FOLIC ACID
FLUTICASONE FUROATE\SALMETEROL vs FOLINIC ACID
Official FDA Label for FLUTICASONE FUROATE\SALMETEROL
Official prescribing information from the FDA-approved drug label.